Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Schmidt

Showing results (271-280 of 350) with videos related to

Pageof 35
Sort By:
The New Phytologist|January 22, 2019
Protein and metabolite composition of Arabidopsis stress granulesMonika Kosmacz, Michał Gorka, Stephan Schmidt, et al.
Journal of Neurology|January 4, 2022
Long-term real-world effectiveness and safety of fingolimod over 5 years in GermanyTjalf Ziemssen, Michael Lang, Stephan Schmidt, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2023
High-throughput screening for prescribing cascades among real world statin initiatorsScott M Vouri, Earl J Morris, Marta Walsh, et al.
Plos One|February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validationsArnold Louie, Michael Neely, Sarah Kim, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 26, 2019
Mode of delivery and mortality and morbidity for very preterm singleton infants in a breech position: A European cohort studyStephan Schmidt, Mikael Norman, Bjorn Misselwitz, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 19, 2019
Real-world persistence and benefit-risk profile of fingolimod over 36 months in GermanyTjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Contemporary Clinical Trials|January 20, 2019
Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methodsMonica Tang, Kathryn V Blake, John J Lima, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Journal of the American Medical Directors Association|February 27, 2025
Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care SettingsYu-Jung Jenny Wei, Almut G Winterstein, Siegfried Schmidt, et al.
Pageof 35

Showing results (271-280 of 350) with videos related to

Sort By:
Pageof 35
The New Phytologist|January 22, 2019
Protein and metabolite composition of Arabidopsis stress granulesMonika Kosmacz, Michał Gorka, Stephan Schmidt, et al.
Journal of Neurology|January 4, 2022
Long-term real-world effectiveness and safety of fingolimod over 5 years in GermanyTjalf Ziemssen, Michael Lang, Stephan Schmidt, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2023
High-throughput screening for prescribing cascades among real world statin initiatorsScott M Vouri, Earl J Morris, Marta Walsh, et al.
Plos One|February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validationsArnold Louie, Michael Neely, Sarah Kim, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 26, 2019
Mode of delivery and mortality and morbidity for very preterm singleton infants in a breech position: A European cohort studyStephan Schmidt, Mikael Norman, Bjorn Misselwitz, et al.
Clinical Pharmacology and Therapeutics|October 19, 2020
Quantitative Benefit-Risk Assessment of P-gp-Mediated Drug-Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal ImpairmentKarthik Lingineni, Nashid Farhan, Sarah Kim, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 19, 2019
Real-world persistence and benefit-risk profile of fingolimod over 36 months in GermanyTjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Contemporary Clinical Trials|January 20, 2019
Genotype tailored treatment of mild symptomatic acid reflux in children with uncontrolled asthma (GenARA): Rationale and methodsMonica Tang, Kathryn V Blake, John J Lima, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Journal of the American Medical Directors Association|February 27, 2025
Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care SettingsYu-Jung Jenny Wei, Almut G Winterstein, Siegfried Schmidt, et al.
Pageof 35